Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Myfembree
Pharma
Sumitomo Pharma lays off 400 US staffers as sales slide
The company, which makes Myfembree, Gemtesa and Orgovyx, previously let go of 500 staffers last summer.
Zoey Becker
Mar 5, 2024 5:35pm
Myovant endometriosis survey shows crippling effect on women
May 19, 2023 7:25am
Myovant rejects Sumitomo's buyout offer—at least for now
Oct 3, 2022 11:04am
Myovant, Pfizer's Myfembree nabs FDA nod for endometriosis
Aug 8, 2022 11:06am
Myovant touts Pfizer-partnered drug launch plans
Jul 29, 2022 7:20am
Analyst says FDA appears to be 'raising the regulatory bar'
Apr 13, 2022 10:20am
